Effect of antiretroviral therapy on HIV reservoirs in elite controllers. - Wikidata - wikimedia - TriplyDB

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

http://www.wikidata.org/entity/Q37212990

about

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions.B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers Candida esophagitis in a human immunodeficiency virus-1-positive elite controller with hepatitis C virus cirrhosis.Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation Human Immunodeficiency Virus (HIV).HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.Multiple Origins of Virus Persistence during Natural Control of HIV Infection.Post-Treatment Controllers: Role in HIV "Cure" Research.Use of broadly neutralizing antibodies for HIV-1 prevention.Persistent HIV-1 replication during antiretroviral therapy.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens [Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].HIV reservoirs as obstacles and opportunities for an HIV cure.A Human Immunodeficiency Virus Controller With a Large Population of CD4(+)CD8(+) Double-Positive T Cells.AIDS virus seeks refuge in B cell follicles.Antiretroviral therapy in the elite controller: justified or premature?Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy.Current Treatment Options for HIV Elite Controllers: a Review

P2860

Q34450282-2B672C47-6CDC-4B7F-BF37-19C533D2C48D Q34510410-CD5DBE5A-87D7-438C-B076-18085C445AB1 Q35058635-BD07B1CF-537D-4AB6-B5C4-4042A81582C1 Q35072016-E763FA83-56DC-4D52-A44D-5A4CC8506721 Q35408098-15850E63-C52F-4D27-9208-DE6093B3B686 Q35661912-013F8494-6038-40EB-B947-4178AEADE0EC Q36638690-08576838-4565-44EB-B7F0-9FC7F87473EF Q36833017-C858173A-1822-45CA-A167-0D8DDA64E8C9 Q37002564-208028CD-8DF3-44A9-9864-A8D1FB67E5AC Q37045832-51E0DC94-D698-4F5F-9635-A1BCE90DB532 Q37643772-6B563C2C-C7F2-432B-A61D-33D6C070F8EE Q38379102-7BBFBA7C-F6D7-4D55-B65F-01B46151F304 Q38701493-62C53848-A50C-4421-9E81-3443822AFAC7 Q38764543-A008E38E-83EF-473F-A55F-3F6C20368492 Q38808266-F470B063-8D6B-43A4-B9B5-E33E12CE9AC3 Q40142539-882AA82D-BC1C-49E5-A6F7-58B958DBB120 Q40695938-B044529B-DA1D-4516-A82B-60D2CADA9EB1 Q40942917-BFCC103F-3DBE-4E20-900F-800FF91307DD Q41216521-EA1CB6EB-C95E-4E2F-9254-7A7969423AC6 Q42121597-EC7CE53F-3992-48D7-A156-C15E26805D0A Q42172382-77B3633B-AAD6-4782-8129-92681992F82F Q44462394-61E10EED-A92E-44DA-81D8-3BD15E3D03EE Q52313087-2393C9C1-66FB-49AE-AE18-FF5B7F92BC52 Q57825309-74D2EF90-E461-4AE6-BE3D-BFC77AD1B098

P2860

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

http://www.wikidata.org/entity/Q37212990

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@en

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@nl

type

label

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@en

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@nl

prefLabel

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@en

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@nl

P1433

Q37212990-D5C081D1-E871-4D27-95ED-59E18A2039A0

P1476

Q37212990-E021BFD3-10AC-4B02-A632-7A2D573FEBC9

P2093

Q37212990-27AE52A4-70BD-4B92-B97F-632233AABF87

Q37212990-63E641E5-7B16-4BB0-AC48-87A2661026D6

Q37212990-66D7E99E-8CB7-40C1-A6B0-ADF97A216033

Q37212990-9CB3BED1-9477-41EC-A76D-7F422C800549

Q37212990-A18F5EBE-F789-4068-AC7F-4C7C478AE89A

Q37212990-ACBD5166-2EB4-4E59-AD90-B6B73A931DEE

Q37212990-B8F78213-2A16-4AF4-BA3D-45774039B541

Q37212990-C404E1BB-EE7E-48E6-9B19-DB26A650F0E3

Q37212990-D2B1AAD4-B9EB-4EBF-8797-5FD65E1C526F

Q37212990-E17BB3DF-686D-4AFB-88A6-C6BD01B44DD5

P2860

Q37212990-1B62D3DE-41A9-4F4D-A15E-01C83A7E5940

Q37212990-311DAF32-5445-451B-8F7E-0B1777720D66

Q37212990-3EC7913F-0EF1-4F98-BC2B-AED57587D24D

Q37212990-50FB793E-1A20-44D6-9339-3F430E96F74C

Q37212990-55748390-FB16-4310-B6A7-172F88AB253E

Q37212990-5BB29A66-CAA6-4D7E-92D1-60492D95770D

Q37212990-5BBBF8C3-EB2A-4CE7-9E5F-841AE8203731

Q37212990-655CBBEC-A068-40CD-819B-5313B8D81AEC

Q37212990-6F397B62-03AC-4FD1-8D0A-11CCB727567B

Q37212990-706036DD-16FC-48E0-826F-81B63020C699

P304

Q37212990-62792C82-87F0-41A3-B7E5-AB101CAD5130

P31

Q37212990-FE918832-A33B-4166-AE65-E170D7E7634C

P356

Q37212990-F6706FC6-5EDF-4FFF-9908-41CC2EFF7979

P407

Q37212990-6B730BD7-F6C3-4CFB-B5D1-C4D11D3148A5

P433

Q37212990-124FA6AA-B3A9-42CE-919D-DCEA7BF9E872

P478

Q37212990-E12FC283-D72F-4171-A685-2EB374898566

P50

Q37212990-67FB0C0F-816A-439A-9609-5D76F5DE584A

Q37212990-6BF927C6-50E9-4B67-A0A7-B7731ADF723D

Q37212990-A7514464-E13D-47C5-AD65-3894703EFA92

Q37212990-C424F9CB-9E21-42B7-AEFE-FD912F0F971F

Q37212990-DEC8E022-E87E-4766-9294-5F7C26143A65

P577

Q37212990-E635276F-2CAD-4D3E-A5A5-B7D96588DFDA

P5875

Q37212990-49127CD8-6DF8-421E-82A0-F7A655F4C93E

P698

Q37212990-AB2C5810-E128-4896-A854-26FE5B04454E

P921

Q37212990-B76B8110-DB78-41E9-AB15-38787897EFC3

Q37212990-F104A7D2-A17A-4140-8253-C847CA368E77

P932

Q37212990-00A0B5F1-D148-4E57-B754-6CE82326A685

P356

P1433

The Journal of Infectious Diseases

P1476

Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

@en

P2093

Cecilia T Costiniuk

http://www.w3.org/2001/XMLSchema#string

Colin Kovacs

http://www.w3.org/2001/XMLSchema#string

Connie J Kim

http://www.w3.org/2001/XMLSchema#string

Danielle Murray

http://www.w3.org/2001/XMLSchema#string

Erika Benko

http://www.w3.org/2001/XMLSchema#string

Gabor Kandel

http://www.w3.org/2001/XMLSchema#string

J Shawn Justement

http://www.w3.org/2001/XMLSchema#string

Jana Blazkova

http://www.w3.org/2001/XMLSchema#string

Joseph P Casazza

http://www.w3.org/2001/XMLSchema#string

Mario Ostrowski

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

HIV-1 continues to replicate and evolve in patients with natural control of HIV infection

Towards an HIV cure: a global scientific strategy

A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy.

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.

Immunogenetics of spontaneous control of HIV

T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors

Antiretroviral therapy and management of HIV infection.

Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

P304

1443-1447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIT306

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Claire W Hallahan

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248706007

http://www.w3.org/2001/XMLSchema#string

P698

23847057

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3789563

http://www.w3.org/2001/XMLSchema#string